Emicizumab prophylaxis for the treatment of people with moderate or mild Hemophilia A without Factor VIII inhibitors: results from the primary analysis of the HAVEN 6 study
| Autor: | Oldenburg, J, Hermans, C, Negrier, C, Lehle, M, Chowdary, P, Catalani, O, Jiménez-Yuste, V, Schmitt, C, Ventriglia, G, Windyga, J, Kiialainen, A, d’Oiron, R, Moorehead, P, Koparkar, S, Teodoro, V, Shapiro, D A |
|---|---|
| Zdroj: | Hämostaseologie; February 2023, Vol. 43 Issue: 1, Number 1 Supplement 1 |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|